Lipid-based nanoformulations for peptide delivery

DocumentFichier
Fichier pdf chargé le 23/03/2016 à 16:34:31
Accès identifié
(version éditeur)
Request
TitreLipid-based nanoformulations for peptide delivery
Type de publicationArticle de revue
AuteurMatougui, Nada , Boge, Lukas, Groo, Anne-Claire , Umerska, Anita-Monika , Ringstad, Lovisa, Bysell, Helena, Saulnier, Patrick
1, 2
PaysPays-Bas
EditeurElsevier
TypeArticle scientifique dans une revue à comité de lecture
Année2016
LangueAnglais
Date11 Avril 2016
Pagination80-97
Volume502
Section1-2
Titre de la revueInternational Journal of Pharmaceutics
ISSN1873-3476
Mots-clésdrug delivery, Lipids, Nanoformulations, Peptides
Résumé en anglais

Nanoformulations have attracted a lot of attention because of their size-dependent properties. Among the array of nanoformulations, lipid nanoformulations (LNFs) have evoked increasing interest because of the advantages of their high degree of biocompatibility and versatility. The performance of lipid nanoformulations is greatly influenced by their composition and structure. Therapeutic peptides represent a growing share of the pharmaceutical market. However, the main challenge for their development into commercial products is their inherent physicochemical and biological instability. Important peptides such as insulin, calcitonin and cyclosporin A have been incorporated into LNFs. The association or encapsulation of peptides within lipid-based carriers has shown to protect the labile molecules against enzymatic degradation. This review describes strategies used for the formulation of peptides and some methods used for the assessment of association efficiency. The advantages and drawbacks of such carriers are also described.

URL de la noticehttp://okina.univ-angers.fr/publications/ua14547
DOI10.1016/j.ijpharm.2016.02.019
Autre titreInt J Pharm
Identifiant (ID) PubMed26899976